Academics + Pharma = Big Bucks; New CAR-T Warnings; Patients Seek Cancer Tests
(MedPage Today) -- Amid controversy and discussions about the high cost of cancer drugs, some academic medical centers profit handsomely from pharma-paid royalties on drugs developed with public funding. (Los Angeles Magazine)
The FDA has mandated...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news
More News: Academia | Cancer | Cancer & Oncology | Funding | Hematology | Pharmaceuticals | Warnings